Editorial
Can we cure metastatic EGFR-mutated lung cancer today?
Translational Cancer Research
2023;
12
(2)
:209-212
.
(28 February 2023)
Precise identification of the intersegmental plane for lung cancer segmentectomy
Translational Cancer Research
2023;
12
(2)
:213-216
.
(28 February 2023)
Explainable vs. interpretable artificial intelligence frameworks in oncology
Translational Cancer Research
2023;
12
(2)
:217-220
.
(28 February 2023)
The role of bronchoscopy as a novel approach in preoperative lung marking for early-stage lung cancer
Translational Cancer Research
2023;
12
(2)
:221-225
.
(28 February 2023)
Beauty is in the explainable artificial intelligence (XAI) of the “agnostic” beholder
Translational Cancer Research
2023;
12
(2)
:226-229
.
(28 February 2023)
Primary breast mucinous cystadenocarcinoma—histopathological analysis
Translational Cancer Research
2023;
12
(2)
:230-232
.
(28 February 2023)
Transthoracic lung biopsy: diagnostic accuracy and complications
Translational Cancer Research
2023;
12
(2)
:233-235
.
(28 February 2023)
Original Article
Down-regulation of FBP1 in lung adenocarcinoma cells promotes proliferation and invasion through SLUG mediated epithelial mesenchymal transformation
Translational Cancer Research
2023;
12
(2)
:236-246
.
(28 February 2023)
Pyrotinib for HER2-positive metastatic breast cancer: a systematic review and meta-analysis
Translational Cancer Research
2023;
12
(2)
:247-256
.
(28 February 2023)
Prognostic and immunological role of alpha-L-fucosidase 2 (FUCA2) in hepatocellular carcinoma
Translational Cancer Research
2023;
12
(2)
:257-272
.
(28 February 2023)
A five-gene expression signature of centromeric proteins with prognostic value in lung adenocarcinoma
Translational Cancer Research
2023;
12
(2)
:273-286
.
(28 February 2023)
Knockdown of MEF2D inhibits the development and progression of B-cell acute lymphoblastic leukemia
Translational Cancer Research
2023;
12
(2)
:287-300
.
(28 February 2023)
Cytoreductive partial and radical nephrectomies provide equivalent oncologic outcomes in T1–2M1 renal cell carcinoma
Translational Cancer Research
2023;
12
(2)
:301-309
.
(28 February 2023)
REGγ promotes mantle cell lymphoma cell apoptosis by downregulating NF-κB signaling
Translational Cancer Research
2023;
12
(2)
:310-320
.
(28 February 2023)
Extracellular matrix-based gene signature for predicting prognosis in colon cancer and immune microenvironment
Translational Cancer Research
2023;
12
(2)
:321-339
.
(28 February 2023)
Leukoencephalopathy in children with acute lymphoblastic leukemia after chemotherapy: a retrospective monocenter study
Translational Cancer Research
2023;
12
(2)
:340-350
.
(28 February 2023)
Biological effects of prostaglandin E2-EP4 antagonist (AAT-008) in murine colon cancer in vivo: enhancement of immune response to radiotherapy and potential as a radiosensitizer
Translational Cancer Research
2023;
12
(2)
:351-358
.
(28 February 2023)
Problems and countermeasures for surgical resection of primary pulmonary artery intimal sarcoma
Translational Cancer Research
2023;
12
(2)
:359-366
.
(28 February 2023)
Effects of p-cresol, a uremic toxin, on cancer cells
Translational Cancer Research
2023;
12
(2)
:367-374
.
(28 February 2023)
Effect of the hospital-community-family (HCF) nutritional management on patients with esophageal and head and neck cancers undergoing radiotherapy: a randomized control trial
Translational Cancer Research
2023;
12
(2)
:375-386
.
(28 February 2023)
Construction of a predictive model for breast cancer metastasis based on lncRNAs
Translational Cancer Research
2023;
12
(2)
:387-397
.
(28 February 2023)
Review Article
The evidence for Mycobacterium avium subspecies paratuberculosis (MAP) as a cause of nonsolar uveal melanoma: a narrative review
Translational Cancer Research
2023;
12
(2)
:398-412
.
(28 February 2023)
Case Report
A diagnostic challenge of mysterious bone pain caused by tumor-induced osteomalacia with multiple tumors: a case report
Translational Cancer Research
2023;
12
(2)
:413-420
.
(28 February 2023)
Conservative treatment for residual lung congestion after left upper trisegmentectomy: a case report
Translational Cancer Research
2023;
12
(2)
:421-426
.
(28 February 2023)
Successful treatment with osimertinib for nonmucinous bronchioloalveolar carcinoma with massive bronchorrhea and respiratory failure: a case report and literature review
Translational Cancer Research
2023;
12
(2)
:427-433
.
(28 February 2023)
Intracranial complete remissions in an aumolertinib-treated EGFR mutation-positive non-small cell lung cancer (NSCLC) patient with symptomatic brain metastases and Eastern Cooperative Oncology Group performance status (ECOG PS) up to 4: a case report
Translational Cancer Research
2023;
12
(2)
:434-438
.
(28 February 2023)
Long-term survival of patients with intracranial metastases from thyroid cancer presenting with seizures: a case report and literature review
Translational Cancer Research
2023;
12
(2)
:439-446
.
(28 February 2023)
Editorial Commentary
CD66b as a prognostic and predictive biomarker in patients with non-small cell lung cancer treated with checkpoint blockade immunotherapy
Translational Cancer Research
2023;
12
(2)
:447-451
.
(28 February 2023)
